AI Powerhouse Sees 853% Increase From Connecticut Billionaire
Nvidia (NASDAQ: NVDA) has rapidly cemented its place as one of the most sought-after stocks after seizing the role of toll road through which all big tech must travel to enter the artificial intelligence ecosystem.
Recently, Nvidia drew interest from billionaire investor Paul Tudor Jones, who raised his position by a staggering 853% to 273,294 shares, » Read more about: AI Powerhouse Sees 853% Increase From Connecticut Billionaire »
Read More
Market Commentary: Toss This Burrito Stock Now?
Investors crave companies with exceptional long-term capital growth, and Chipotle Mexican Grill has emerged as a rare gem. Over the past five years, its share price skyrocketed by almost 5x, easily outperforming the S&P 500’s 63%+ return since 2018.
But what sets this humble burrito outlet apart from the rest, and is its stock overvalued?
» Read more about: Market Commentary: Toss This Burrito Stock Now? »
Read More
Alert: 1 Under the Radar Stock BIG Money Is Buying
Investment Alert: Buy Medtronic (MDT) Under $89
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
We last reported on Medtronic in March when the stock was hovering around the high-$70s.
» Read more about: Alert: 1 Under the Radar Stock BIG Money Is Buying »
Read More
Market Commentary: How To Spot The Next Big Move
Want to know when the next big move is coming in a stock? It’s not as hard as it might seem to figure it out.
To begin, look to the past. If a big move has already occurred, you could be looking at a good candidate. Next, you want to see that a stock has paused or consolidated for a while so that the moving averages “catch up”
» Read more about: Market Commentary: How To Spot The Next Big Move »
Read More
1 Titan Health Stock Is Way Too Cheap
Merck & Co. (NYSE: MRK) might be best known for its drugs like Keytruda and Gardasil, but those blockbusters haven’t been enough to get shareholders excited as the share price has fallen under water this year, down 6%.
It may well be a pharmaceutical powerhouse but recent price weakness suggests that Merck may be flying under the radar for investors,
» Read more about: 1 Titan Health Stock Is Way Too Cheap »
Read MoreThe Burst
The Secret Buffett Won’t Tell You
Most traders are consumed by day-to-day share price fluctuations of their stock portfolios but few spend the time to think about the economics of compounding wealth, and how it can be done to achieve enormous gains.
One secret that Buffett unlocked in growing massive wealth was realizing what would happen to the dividend of Coca Cola over time.
» Read more about: The Secret Buffett Won’t Tell You »
Read MoreThe Spotlight
Spotlight: Dine On Steak After This Brazilian Breakout
Rates are going up everywhere, at least that’s what the financial press would have you believe. On July 26, Federal Reserve Chairman Jerome Powell oversaw a rate hike that placed interest rates at 22 year highs, pegging them at 5.25-5.50%.
The market had largely priced in the rate hike and so the S&P 500 fell just 0.17% on the day.
» Read more about: Spotlight: Dine On Steak After This Brazilian Breakout »
Read More